Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease
Stephanie Langella,Kyra Bonta,Yinghua Chen,Yi Su,Daniel Vasquez,David Aguillon,Natalia Acosta-Baena,Ana Y. Baena,Gloria Garcia-Ospina,Margarita Giraldo-Chica,Victoria Tirado,Claudia Muñoz,Silvia Ríos-Romenets,Claudia Guzman-Martínez,Jeremy J. Pruzin,Valentina Ghisays,Joseph F. Arboleda-Velasquez,Kenneth S. Kosik,Pierre N. Tariot,Eric M. Reiman,Francisco Lopera,Yakeel T. Quiroz
DOI: https://doi.org/10.1186/s13195-024-01572-y
2024-10-02
Alzheimer s Research & Therapy
Abstract:Apolipoprotein E ( APOE ) genotypes have been suggested to influence cognitive impairment and clinical onset in presenilin-1 ( PSEN1 ) E280A carriers for autosomal dominant Alzheimer's disease (ADAD). Less is known about their impact on the trajectory of biomarker changes. Neurofilament light chain (NfL), a marker of neurodegeneration, begins to accumulate in plasma about 20 years prior to the clinical onset of ADAD. In this study we investigated the impact of APOE ε4 and ε2 variants on age-related plasma NfL increases and cognition in PSEN1 E280A mutation carriers.
neurosciences,clinical neurology